The results suggest that pancreatic cancer cells are similar with normal pancreatic cells with the same changing trend for the expression of NF-κB, TNF-α, SIRT1, and LC3 II after picroside II treatment. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.